ClinicalTrials.gg
CompletedNCT03856307Updated Jul 24, 2019

Reliability of Simple Sonographic Findings Acquired With Hand-held Apparatuses to Inform Obstetric Diagnosis

An observational study in Obstetric Complication, Vaginal Bleeding and Eclampsia Preeclampsia, sponsored by Doctors with Africa - CUAMM. Completed at 1 site in Sierra Leone. Open to female participants. Per ClinicalTrials.gov, last updated 2019-07-24.

Sponsored by Doctors with Africa - CUAMM · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
300
Sex
Female
01

Study summary

the study aims to assess the reliability of ultrasound findings measured by hand held ultrasound probes used by operators with variable experience in a low resource hospital.

Read the detailed description

Rationale: The majority of obstetric emergencies are identified through clinical examination, which cannot be substituted by ultrasound. However, just as a laboratory exam, ultrasonograpy can provide swift point of care information on fetus presentation, viability, placenta position, quantity of amniotic fluid and presence of abdominal fluid to inform the clinical reasoning and therapeutic escalation. Ultrasound literature in low-resource settings has favoured antenatal care (ANC) rather than the emergency setting. Also, hand-held ultrasound machines may not be as performant as traditional machines used by expert operators but to date is still to be tested in a low resource setting.

Objective: to assess the reliability of ultrasound findings measured by hand held ultrasound probes used by operators with variable experience in a low resource hospital.

Hypothesis: There is substantial agreement between simple ultrasound findings identified using hand held ultrasound devices and the reference standard.

Study design: a prospective observational diagnostic accuracy study. Study population: parturients admitted to the Princess Christian Maternity Hospital (PCMH) in Freetown, Sierra Leone.

Sample size: no formal sample size calculation is performed. Based on current rates of admissions to the PCMH we expect to perform obstetrical ultrasound scan in at least 300 patients during a 2-months study period.

Methods: 4 trained physicians (3 naive and 1 intermediate ultrasound users) will perform the ultrasound investigations using the hand held device and complete a structured predefined report form of obstetric ultrasound findings at patient admission or according to clinical indications after admission. These will be compared with the reference standard, i.e. an ultrasound examination performed by a specialist gynecologist/obstetrician using a conventional apparatus in the hospital ultrasound room.

Main study parameters/primary endpoints: The mean diagnostic accuracy among nine ultrasound obstetric findings collected with hand held devices versus the reference standard.

02

Conditions studied

  • Obstetric Complication
  • Vaginal Bleeding
  • Eclampsia Preeclampsia
  • Obstructed Labor
  • Antepartum Hemorrhage
03

In context

Uterine Hemorrhage

90 studies on the registry are indexed under Uterine Hemorrhage; 13 are open to participants now.

This study's enrollment of 300 is above the median of 122 across 27 observational studies indexed under Uterine Hemorrhage.

Browse Uterine Hemorrhage studies →

Lead sponsor

Doctors with Africa - CUAMM is the lead sponsor of 7 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

  • Vaginal bleeding in early pregnancy:Vaginal bleeding or cramping, with amenorrhea or positive pregnancy test \<22 weeks of gestation
  • Pre-eclampsia:Blood pressure ≥140/90 (at least 2 recordings, 4 hours apart) PLUS any of: proteinuria (at least 2+ on dipstick, headache, generalized oedema, visual disturbance).
  • APH third trimester: Vaginal bleeding after 22 weeks of pregnancy or in labour before giving birth. May have final diagnosis of abruptio placentae, placenta previa and ruptured uterus.
  • Prolonged/Obstructed labour: Prolonged latent or active phase, cephalopelvic disproportion, obstructed labor, inadequate uterine activity, prolonged expulsive phase.
  • High risk pregnancy in ANC defined by hospital protocol

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Admitted to the emergency department, outpatient department, in-patient department or antenatal care (ANC) of the PCMH during the study period.
  • Fulfills one or more of the five inclusion categories: i.e. vaginal bleeding in early pregnancy, pre-eclampsia, prolonged/obstructed labor, antepartum hemorrhage (APH) and other high risk pregnancies encountered in ANC.

Exclusion criteria

Exclusion Criteria:

  • Ultrasound examination not feasible, e.g., due to electricity breakdown, or physical absence or unavailability of the trained sonographers.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
300 participants (actual)
Target follow-up
3 Months
Patient registry
Yes

Interventions

  • Diagnostic testpoint of care ultrasound

    to evaluate the reliability of simple pre-specified ultrasound findings acquired at the bedside with a hand-held apparatus with regards to five clinical scenarios most commonly encountered in the hospital, i.e. vaginal bleeding in early pregnancy, pre-eclampsia, prolonged/obstructed labor, antepartum hemorrhage (APH) and high risk pregnancies encountered in ANC.

06

What researchers measure

Primary outcomes

  1. composite reliability of simple obstetric ultrasound findings collected by hand held ultrasound devices in a busy urban low resource setting.

    the mean aggregated diagnostic accuracy between the ultrasound findings collected via hand held devices as compared to the conventional apparatus.

    Time frame: From admission to 48 hours later

Secondary outcomes

  1. reliability for each pre-defined ultrasound finding

    Detailed diagnostic accuracy for each of the nine ultrasound findings.

    Time frame: From admission to 48 hours later

  2. variance of the reliability between naïve and intermediate operators.

    Inter-observer agreement on ultrasound findings between naïve and intermediate operators.

    Time frame: From admission to 48 hours later

  3. quality of images acquired with the hand held apparatus.

    Mean 'quality of image score' (0-4) for each of the nine ultrasound findings.

    Time frame: From admission to 48 hours later

07

Study locations

1 site
  • Princess Christian Maternal Hospital
    Freetown, Sierra Leone
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2019 to primary completion in Apr 2019, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 25, 2019
First posted
Feb 27, 2019
StartActual
Mar 1, 2019
Primary completionActual
Apr 1, 2019
CompletionActual
Jun 1, 2019
Last update
Jul 24, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 24, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03856307
Lead sponsor
Doctors with Africa - CUAMM
Responsible party
Yuichi Kodaira (Medical Doctor, Doctors with Africa - CUAMM) — Principal investigator
First posted
Feb 27, 2019
Start date
Mar 1, 2019
Primary completion
Apr 1, 2019
Completion
Jun 1, 2019
Last update
Jul 24, 2019

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion